Answers are grounded in this paper and cite their sources.
Spatial transcriptomics demonstrates cellular stress and immune signatures in systemic sclerosis, suggesting potential for early detection.
Background/Aims The skin from patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS) already exhibits fibrotic alterations such as collagen deposition and perivascular infiltration, despite the absence of clinically detectable skin thickening. A distinct immune-mediated structural organization across the epidermis, sub-epidermal region, and dermis, is involved in both early and late stages of SSc .The sub-epidermal perivascular area, located between these layers, serves as a crucial immune-fibro-vascular niche that may play a role in early fibrotic remodeling useful for determining SSc progression and identifying novel therapeutic applications. Therefore, we aim to identify key signaling and cell types involved in the sub-epidermal perivascular regions within Very Early Diagnosis of Systemic Sclerosis (VEDOSS) compared to those with established disease and healthy control using spatial transcriptomic analyses. Methods We employed digital spatial transcriptomics to map whole genome-wide transcriptome expression in the area immediately surrounding CD34-stained vessels in the sub-epidermal regions. Differentially expressed genes (p < 0.05, log2FC>0) were analyzed to identify relevant canonical pathways and biological processes. Results Six skin biopsies from VEDOSS were compared with six biopsies from healthy individuals or patients with developed systemic sclerosis (SSc). Cell deconvolution revealed that the sub-epidermal region was dominated by diverse fibroblast subsets and vascular endothelial cells, with notable representation of immune populations such as T cells and macrophages. Disease-associated shifts included early depletion of secretory papillary fibroblasts in VEDOSS, enrichment of lymphatic endothelial cells, and progressive erythrocyte loss. Pathway Analysis of the sub-epidermal region in VEDOSS compared to healthy controls revealed significant upregulation of key stress and immune-related pathways. Notable among these were Cellular response to hypoxia, Oxidative Phosphorylation, Neutrophil Degranulation, Mitochondrial Dysfunction, and pulmonary idiopathic fibrosis signaling pathway, highlighting early metabolic activation, cellular stress, immune activation, and fibrosis in this region. Key genes significantly upregulated included cyclophilin A, CD47, ATP5MG, COX10, NDUFB9, S100A4, COL1A1, COL16A1, COL17A1, COL21A1, FN1, PIK3R2, PIK3C2B, PDGFRB, implying cellular remodeling and stromal transitions through associated signaling pathways involved in fibrosis. Conclusion We demonstrate that the sub-epidermal perivascular region is a transcriptionally dynamic niche in VEDOSS skin, where early immune, metabolic, and fibrotic reprogramming converges to initiate stromal remodeling before the onset of clinically detectable fibrosis and progression to SSc. Disclosure I.E. Bamigbola: None. J. Vadakekolathu: None. M. Minerba: None. R. Ross: None. Y. El-Sherbiny: None. F. Del Galdo: Grants/research support; has received funding for research from AbbVie/Abbott, argenx, AstraZeneca, Boehringer-Ingelheim, Calluna, Deepcure, Engitix, GlaxoSmithKline (GSK), Janssen, Merck/MSD, Miltenyi, Mitsubishi-Tanabe, Novartis, Ono, Quell, RelationX, Serono, Syntara, Ventus, and ZuraBio.
No takes yet. Share an insight, caveat, or question.
Bamigbola et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: